Real-life Experiences with Galcanezumab disclosed New Predictors for Response

Sadeleştirilmiş öğe sayfası
dc.contributor.authorDikmen, Pinar Yalinay
dc.contributor.authorBaykan, Betul
dc.contributor.authorUluduz, Derya
dc.contributor.authorOzge, Aynur
dc.contributor.authorAydinlar, Elif Ilgaz
dc.contributor.authorPolat, Burcu
dc.contributor.authorKarli, Necdet
dc.contributor.authorTepe, Nermin
dc.contributor.authorCelebisoy, Nese
dc.contributor.authorToktas, Hayal Ergin
dc.contributor.authorNiflioglu, Buket
dc.contributor.authorKaraci, Rahsan
dc.contributor.authorDomac, Fusun Mayda
dc.contributor.authorUluduz, Ezgi
dc.contributor.authorSoyukibar, Tuba Erdogan
dc.contributor.authorOksuz, Nevra
dc.contributor.authorErtas, Mustafa
dc.date.accessioned2025-10-16T15:14:43Z
dc.date.issued2023
dc.description.abstractInternational Headache Congress (IHC), Seoul, SOUTH KOREA, SEP 14-17, 2023
dc.identifier.otherWOS:001125614000398
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6258
dc.publisherSAGE PUBLICATIONS LTD
dc.sourceCEPHALALGIA
dc.titleReal-life Experiences with Galcanezumab disclosed New Predictors for Response
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS